-
Mashup Score: 0
July St. Jude-VIVA Survivorship Series 3: Medulloblastoma Friday, 16 February 2024 8:00PM – 9:30PM (UTC+8 Singapore Time) | 7:00AM – 8:30AM (UTC-5 Memphis Time) Check your Time Zone VIVA Foundation for Children with Cancer in collaboration with the St. Jude Children’s Research Hospital is excited to bring a third series of the St Jude-VIVA Survivorship! This series will feature case presentations followed by discussion of the data informing current clinical practice recommendations and guidelines, as
Source: mailchi.mpCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 5LIBRETTO-431: Selpercatinib in RET Fusion–Positive NSCLC - 11 month(s) ago
A medical oncologist discusses data from the LIBRETTO-431 clinical trial looking at first-line selpercatinib vs chemotherapy and pembrolizumab in RET fusion–positive NSCLC.
Source: www.cancernetwork.comCategories: General Medicine News, Oncologists2Tweet-
LIBRETTO-431: Selpercatinib in RET Fusion–Positive NSCLC https://t.co/PSa7UbmhaF via @@CancerNetwrk
-
-
Mashup Score: 19Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer - 11 month(s) ago
NTRK fusions result in constitutively active oncogenic TRK proteins responsible for ∼ 0.2 % of non-small cell lung cancer (NSCLC) cases. Approximately…
Source: www.sciencedirect.comCategories: General Medicine News, Oncologists2Tweet-
Happy to share our #international #review paper on updated #efficacy & #safety of #entrectinib in #NTRK fusion-positive NSCLC! @NTRKers #LCSM @Piuchagarrido @ChengEanChee #precisionmedicine @CUHKMedicine https://t.co/jMdk5Y7lvX
-
-
Mashup Score: 0Health Promo - 12 month(s) ago
Moderator: Prof Wong Chi-sang, Martin (Centre Director, Centre for Health Education and Health Promotion, CUHK) Target Participants: Medical doctors, nurses , community health practitioners, health service providers, academics, and postgraduate and undergraduate students Organiser: Centre for Health Education and Health Promotion, CUHK This series of webinars on infectious disease prevention is supported by the following organisations: The Jockey Club School of Public Health and Primary Care, Hong Kong
Source: www.chep.cuhk.edu.hkCategories: General Medicine News, Oncologists2Tweet-
https://t.co/u60uPpq6gw
-
-
Mashup Score: 5GIST Updates from CTOS 2023 - 1 year(s) ago
Dr. Herbert Loong of the Chinese University of Hong Kong to presented “GIST Updates from CTOS 2023” to GIST patients and caregivers on November 27th at 5pm E…
Source: www.youtube.comCategories: General Medicine News, Oncologists2Tweet-
Thanks @Liferaftgroup for the invite to share with the community GIST Updates from CTOS 2023! https://t.co/8wzMWdjqU8 @ctosociety #CTOSTweeTOS @CUHKMedicine #CUHKSarcoma
-
-
Mashup Score: 2
This report highlights the need for improvements in the early detection of lung cancer and showcases early detection approaches and tools.
Source: www.lungcancerpolicynetwork.comCategories: General Medicine News, Oncologists2Tweet-
As member of @LungPolicy & @APCLC_2023, pleased to share our new report ‘Increasing the earlier detection of lung cancer: a toolbox for change’. #LCSM It highlights importance of detecting #lungcancer earlier & explores different approaches available. https://t.co/uU0MQCCCfw
-
-
Mashup Score: 2GIST Updates from CTOS - The Life Raft Group - 1 year(s) ago
Dr. Herbert Loong will discuss scientific updates relevant to GIST patients that were exhibited at the CTOS 2023 conference.
Source: liferaftgroup.orgCategories: General Medicine News, Oncologists2Tweet-
Come join us on Nov 27 5:00pm ET (Nov 28 6:00am HKT/SGT) as we discuss several key #GIST abstracts that was presented at @ctosociety #CTOS2023 meeting earlier this month. #CTOSTweeTOS. @OncoAlert #Sarcoma @CUHKMedicine #CUHKSarcoma Register at this link: https://t.co/d6oQGfCf00
-
-
Mashup Score: 2
Next-generation sequencing (NGS) diagnostics have shown clinical utility in predicting survival benefits in patients with certain cancer types who are…
Source: www.sciencedirect.comCategories: General Medicine News, Oncologists2Tweet-
https://t.co/wWUtzZNKZ3 https://t.co/6ejquwLpH0
-
-
Mashup Score: 0View Cart - 1 year(s) ago
Oncology Journal Network Highlights
Source: www.elsevier.comCategories: General Medicine News, Oncologists2Tweet-
I’m excited to share that my paper has been featured in a special article collection for #LungCancerAwarenessMonth. Read it now https://t.co/EElMRqF5qm @OncologyAdvance @JTOonline
-
-
Mashup Score: 1【#健康探索號】癌症點為之罕見？康復率比常見癌症低？比其他癌症更難察覺？ - 1 year(s) ago
癌症可怕，罕見癌症更可怕？！今集主持陳心怡請嚟內科腫瘤科專科醫生龍浩鋒，拆解罕見癌症謬誤，以及癌症先兆！💪🏻想知更多健康資訊，即刻瀏覽以下網頁 https://bit.ly/3PWHgPK 好多疾病嘅成因同治療方法，其實都係以訛傳訛！🗣《健康探索號》主持陳心怡每集請嚟唔同專科醫生👨🏻，講解各種疾病成因…
Source: www.youtube.comCategories: Latest Headlines, Oncologists2Tweet-
Had the opportunity to speak about #RareCancers on #MetroRadioHK. Thanks for the opportunity to raise #awareness. Full length #Cantonese recording can be viewed here! 😄 @CUHKMedicine #CUHKSarcoma @_rarecancer @RareCancers @Liferaftgroup https://t.co/JRwXre3x3v via @YouTube
-
[Register Now] St. Jude-VIVA Survivorship Series 3 #4 (16 Feb | 8PM - 9:30PM): https://t.co/wZ5o75urVZ